These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 6126442

  • 1. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
    Tanaka T, Sakuragi N, Fujimoto S, Ichinoe K.
    Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
    [Abstract] [Full Text] [Related]

  • 2. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH.
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [Abstract] [Full Text] [Related]

  • 3. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD, Tagatz GE, Steffes MW.
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [Abstract] [Full Text] [Related]

  • 4. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S, Paradisi R, Fabbri R, Porcu E, Orsini LF, Flamigni C.
    Int J Fertil; 1987 Feb; 32(1):66-70. PubMed ID: 2880819
    [Abstract] [Full Text] [Related]

  • 5. Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
    Check JH, Adelson HG, Stern J, Lauer C.
    Int J Fertil; 1992 Feb; 37(2):103-5. PubMed ID: 1349590
    [Abstract] [Full Text] [Related]

  • 6. Comparison of various therapies for the luteinized unruptured follicle syndrome.
    Check JH, Dietterich C, Nowroozi K, Wu CH.
    Int J Fertil; 1992 Feb; 37(1):33-40. PubMed ID: 1348733
    [Abstract] [Full Text] [Related]

  • 7. [Pregnancy in patients failed to HMG-HCG therapy (author's transl)].
    Uemura T, Suzuki N, Kooguchi J, Tsuchihashi S, Shiojima Y.
    Nihon Funin Gakkai Zasshi; 1976 Jan; 21(1):75-9. PubMed ID: 773720
    [No Abstract] [Full Text] [Related]

  • 8. Observations on the combination of clomiphene citrate-human menopausal gonadotropin-human chorionic gonadotropin in the management of anovulation.
    Jarrell J, McInnes R, Cooke R, Arronet G.
    Fertil Steril; 1981 Jun; 35(6):634-7. PubMed ID: 6788606
    [Abstract] [Full Text] [Related]

  • 9. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
    Muechler EK, Kohler D, Huang KE.
    Int J Fertil; 1981 Jun; 26(4):273-8. PubMed ID: 6120908
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 11. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH, Sy L, Cannon W.
    Am J Obstet Gynecol; 1981 Jul 15; 140(6):629-35. PubMed ID: 6167169
    [Abstract] [Full Text] [Related]

  • 12. Ovulation monitored by serum 17 beta-estradiol and ultrasound: differential ovarian response to human gonadotropins in various anovulatory states.
    Padova G, Briguglia G, Tita P, Arpi ML, Munguira ME, Cafiso F, Cianci A, Ettore G, Pezzino V.
    Acta Eur Fertil; 1988 Jul 15; 19(5):283-6. PubMed ID: 3150888
    [Abstract] [Full Text] [Related]

  • 13. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
    Kooguchi J, Uemura T, Shiojima Y, Iwasaki H.
    Acta Obstet Gynaecol Jpn; 1981 Jun 15; 33(6):777-85. PubMed ID: 6787830
    [Abstract] [Full Text] [Related]

  • 14. Plasma estrogen monitoring of ovulation induction.
    Wu CH.
    Obstet Gynecol; 1975 Sep 15; 46(3):294-8. PubMed ID: 1172219
    [Abstract] [Full Text] [Related]

  • 15. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A, David H, Libal Y, Ballas S.
    Harefuah; 1995 Dec 01; 129(11):455-6, 536. PubMed ID: 8846950
    [Abstract] [Full Text] [Related]

  • 16. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec 01; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 17. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
    Schmidt W, von Holst T.
    Fortschr Med; 1981 Jul 23; 99(27-28):1080-6. PubMed ID: 6790397
    [Abstract] [Full Text] [Related]

  • 18. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
    Abuzeid MI, Yeoman R, Aksel S.
    Fertil Steril; 1987 Feb 23; 47(2):238-43. PubMed ID: 3102284
    [Abstract] [Full Text] [Related]

  • 19. Incidence, recurrence and treatment of the luteinized unruptured follicle syndrome.
    Temmerman M, Devroey P, Naaktgeboren N, Amy JJ, Van Steirteghem AC.
    Acta Eur Fertil; 1984 Feb 23; 15(3):179-83. PubMed ID: 6237540
    [Abstract] [Full Text] [Related]

  • 20. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
    Ferin J, Thomas K, De Hertogh R.
    Acta Endocrinol Suppl (Copenh); 1977 Feb 23; 214():33-42. PubMed ID: 268747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.